OTC Link · Healthcare · Biotechnology
REVIVA PHARMA HLDGS INC
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-12 | Q2 2026 | -0.51 | -0.19 | +62.75% | $0 | ✅ Beat | +0.00% | +8.58% | — |
| 2026-05-13 | Q1 2026 | -0.38 | -0.46 | -21.05% | $0 | ❌ Miss | -0.88% | +11.08% | +94.23% |
| 2026-03-30 |
| Q4 2025 |
| -1.04 |
| -0.57 |
| +45.48% |
| $0 |
| ✅ Beat |
| -2.63% |
| +7.88% |
| +31.33% |
| 2025-11-13 | Q3 2025 | -0.10 | -0.06 | +40.00% | $0 | ✅ Beat | — | — | — |
| 2025-03-31 | Q4 2024 | -0.21 | -0.15 | +28.57% | $0 | ✅ Beat | -34.91% | -37.09% | -6.69% |
| 2024-11-14 | Q3 2024 | -0.25 | -0.25 | +0.00% | $0 | ➖ Inline | -7.02% | +2.48% | +90.08% |
| 2024-08-14 | Q2 2024 | -0.29 | -0.26 | +10.34% | $0 | ✅ Beat | -4.60% | +18.03% | +67.11% |
| 2024-05-14 | Q1 2024 | -0.42 | -0.25 | +40.48% | $0 | ✅ Beat | -6.30% | -28.49% | -17.81% |
Showing last 8 quarters.